Enzo Biochem (ENZ) Short Interest Ratio & Short Volume $0.99 -0.02 (-1.99%) (As of 11/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Enzo Biochem Short Interest DataEnzo Biochem (ENZ) has a short interest of 477,500 shares, representing 1.31% of the float (the number of shares available for trading by the public). This marks a -4.56% decrease in short interest from the previous month. The short interest ratio (days to cover) is 6.3, indicating that it would take 6.3 days of the average trading volume of 125,661 shares to cover all short positions.Current Short Interest477,500 sharesPrevious Short Interest500,300 sharesChange Vs. Previous Month-4.56%Dollar Volume Sold Short$546,737.50Short Interest Ratio6.3 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares52,240,000 sharesFloat Size36,470,000 sharesShort Percent of Float1.31%Today's Trading Volume103,821 sharesAverage Trading Volume125,661 sharesToday's Volume Vs. Average83% Short Selling Enzo Biochem? Sign up to receive the latest short interest report for Enzo Biochem and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENZ Short Interest Over TimeENZ Days to Cover Over TimeENZ Percentage of Float Shorted Over Time Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Enzo Biochem Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024477,500 shares $546,737.50 -4.6%1.3%6.3 $1.15 10/15/2024500,300 shares $565,339.00 -3.4%1.4%7.8 $1.13 9/30/2024518,000 shares $580,160.00 +8.2%1.4%6.9 $1.12 9/15/2024478,700 shares $531,357.00 -5.0%1.3%5.3 $1.11 8/31/2024504,000 shares $574,560.00 -0.8%1.4%5.1 $1.14 8/15/2024507,800 shares $563,658.00 -4.5%1.4%4.3 $1.11 Get the Latest News and Ratings for ENZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enzo Biochem and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024531,800 shares $600,934.00 -10.1%1.5%4.4 $1.13 7/15/2024591,200 shares $691,704.00 -2.3%1.7%4.6 $1.17 6/30/2024605,300 shares $659,777.00 +8.0%1.7%4.6 $1.09 6/15/2024560,500 shares $650,180.00 -6.9%1.6%4.9 $1.16 5/31/2024602,300 shares $716,737.00 -0.2%1.7%5.4 $1.19 5/15/2024603,600 shares $663,960.00 -10.8%1.7%6.1 $1.10 4/30/2024676,700 shares $710,535.00 -7.2%1.9%6 $1.05 4/15/2024729,200 shares $845,872.00 +1.2%2.1%6.9 $1.16 3/31/2024720,600 shares $915,162.00 -1.7%2.0%7.6 $1.27 3/15/2024733,100 shares $901,713.00 +2.5%2.1%7.2 $1.23 2/29/2024715,400 shares $951,482.00 -9.8%2.1%6.3 $1.33 2/15/2024792,900 shares $1.07 million +5.1%2.3%7 $1.35 1/31/2024754,700 shares $950,922.00 -22.8%2.2%7.6 $1.26 1/15/2024978,000 shares $1.36 million -1.6%2.8%9.1 $1.39 12/31/2023994,000 shares $1.38 million -25.3%2.8%9.1 $1.39 12/15/20231,330,000 shares $1.77 million -14.7%3.8%11.8 $1.33 11/30/20231,560,000 shares $1.98 million -3.1%4.4%13.9 $1.27 11/15/20231,610,000 shares $1.98 million -9.0%4.6%13.1 $1.23 10/31/20231,770,000 shares $2.37 million -1.7%5.1%9.8 $1.34 10/15/20231,800,000 shares $2.57 million +0.6%5.2%6 $1.43 9/30/20231,790,000 shares $2.51 million +7.2%5.2%5.4 $1.40 9/15/20231,670,000 shares $2.17 million +13.6%4.8%5 $1.30 8/31/20231,470,000 shares $2.28 million -3.9%3.9%4.4 $1.55 8/15/20231,530,000 shares $2.42 million +5.5%4.0%4.8 $1.58 7/31/20231,450,000 shares $2.15 million +40.8%3.8%5.2 $1.48 7/15/20231,030,000 shares $1.37 million +20.8%3.1%6.5 $1.33 6/30/2023852,900 shares $1.57 million -10.6%2.6%5.3 $1.84 6/15/2023953,500 shares $1.95 million -12.5%2.9%4.8 $2.04 5/31/20231,090,000 shares $2.40 million -8.4%3.3%1.3 $2.20 5/15/20231,190,000 shares $2.83 million -2.5%3.6%1.4 $2.38 4/30/20231,220,000 shares $3.09 million +8.9%3.7%1.4 $2.53 4/15/20231,120,000 shares $2.84 million +8.7%3.4%1.3 $2.54 3/31/20231,030,000 shares $2.50 million +113.8%3.1%1.3 $2.43 3/15/2023481,800 shares $481,800.00 +49.2%1.3%0.6 $1.00This Bull Market Indicator called NVDA at $116 (Ad)Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here 2/28/2023322,900 shares $364,877.00 -6.0%0.9%4.1 $1.13 2/15/2023343,600 shares $439,808.00 -6.8%0.9%4.6 $1.28 1/31/2023368,700 shares $494,058.00 +6.1%1.0%5 $1.34 1/15/2023347,500 shares $528,200.00 +1.0%0.9%5.1 $1.52 12/30/2022344,100 shares $492,063.00 +9.1%1.0%5.2 $1.43 12/15/2022315,300 shares $365,748.00 -21.2%0.9%5.2 $1.16 11/30/2022400,300 shares $796,597.00 +2.4%1.1%8.5 $1.99 11/15/2022391,000 shares $871,930.00 -3.0%1.1%8.3 $2.23 10/31/2022403,100 shares $862,634.00 +5.9%1.1%8.5 $2.14 10/15/2022380,600 shares $806,872.00 -1.8%1.0%8.4 $2.12 9/30/2022387,400 shares $863,902.00 -14.8%1.0%8 $2.23 9/15/2022454,500 shares $1.03 million +12.1%1.2%7 $2.26 8/31/2022405,300 shares $980,826.00 -2.0%1.1%6.1 $2.42 8/15/2022413,400 shares $1.13 million -4.3%1.1%5.9 $2.73 7/31/2022431,900 shares $1.02 million -4.3%1.2%6.1 $2.37 7/15/2022451,400 shares $1.08 million -6.6%1.2%5.9 $2.40 6/30/2022483,300 shares $1.00 million -5.3%1.3%6.3 $2.07 6/15/2022510,200 shares $1.14 million +4.3%1.4%8.4 $2.23 5/31/2022489,300 shares $1.13 million -7.5%1.3%8.5 $2.31 5/15/2022528,900 shares $1.24 million +9.1%1.4%8.8 $2.35 4/30/2022484,800 shares $1.24 million -8.0%1.3%7.7 $2.55 4/15/2022527,000 shares $1.52 million -2.1%1.4%7.9 $2.88 3/31/2022538,500 shares $1.56 million -1.8%1.5%6.5 $2.90 3/15/2022548,300 shares $1.67 million -0.9%1.5%5.5 $3.04 2/28/2022553,200 shares $1.82 million -18.9%1.5%4.9 $3.29 2/15/2022682,400 shares $2.33 million -2.0%1.9%5.6 $3.41 1/31/2022696,100 shares $2.24 million -10.8%1.9%5.2 $3.22 1/15/2022780,700 shares $2.58 million +16.4%2.1%5.6 $3.31 12/31/2021670,900 shares $2.15 million +6.0%1.8%3.5 $3.21 12/15/2021633,000 shares $2.20 million -5.9%1.7%3.1 $3.48 11/30/2021672,600 shares $2.34 million +8.2%1.8%3.6 $3.48 11/15/2021621,900 shares $2.10 million +4.9%1.7%3.3 $3.38 10/29/2021592,700 shares $2.04 million +0.3%1.5%3.1 $3.44 10/15/2021590,700 shares $2.23 million -5.3%1.5%3 $3.78 9/30/2021623,700 shares $2.21 million +8.9%1.5%1.8 $3.54 9/15/2021572,500 shares $1.95 million -2.7%1.4%1.3 $3.40 8/31/2021588,200 shares $2.15 million -0.4%1.4%1.1 $3.66 8/13/2021590,400 shares $1.83 million -13.5%1.4%1 $3.10 7/30/2021682,300 shares $2.22 million -7.8%1.5%1.1 $3.26 7/15/2021739,700 shares $2.30 million -7.5%1.7%1.2 $3.11 6/30/2021800,000 shares $2.54 million -54.8%1.8%1.8 $3.17 6/15/20211,770,000 shares $5.31 million +7.9%4.0%5.1 $3.00 5/28/20211,640,000 shares $5.05 million +0.6%3.7%1.3 $3.08 5/14/20211,630,000 shares $4.82 million No Change3.7%1.4 $2.96 4/30/20211,630,000 shares $5.22 million +9.4%3.7%1.3 $3.20 4/15/20211,490,000 shares $5.01 million +8.8%3.4%1.2 $3.36 3/31/20211,370,000 shares $4.51 million -24.7%3.1%1.1 $3.29 3/15/20211,820,000 shares $5.21 million -3.7%4.1%1.5 $2.86 2/26/20211,890,000 shares $5.58 million -1.6%4.3%5.6 $2.95 2/12/20211,920,000 shares $6.28 million -1.0%4.4%5.7 $3.27This Bull Market Indicator called NVDA at $116 (Ad)Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here 1/29/20211,940,000 shares $5.37 million -1.5%4.4%5.9 $2.77 1/15/20211,970,000 shares $5.89 million +0.5%4.5%6.1 $2.99 12/31/20201,960,000 shares $5.12 million -1.0%4.4%6 $2.61 12/15/20201,980,000 shares $4.99 million +4.2%4.5%6.5 $2.52 11/30/20201,900,000 shares $3.86 million -2.1%4.3%6.3 $2.03 11/15/20201,940,000 shares $3.86 million -22.7%4.4%6.4 $1.99 10/30/20202,510,000 shares $4.92 million +9.1%5.7%8 $1.96 10/15/20202,300,000 shares $4.97 million +2.2%5.2%6.5 $2.16 9/30/20202,250,000 shares $4.75 million -3.0%5.1%4 $2.11 9/15/20202,320,000 shares $5.43 million +6.9%5.2%2.6 $2.34 8/31/20202,170,000 shares $4.62 million -3.1%4.9%2.4 $2.13 8/14/20202,240,000 shares $5.60 million -2.2%5.1%2.4 $2.50 7/31/20202,290,000 shares $5.45 million -7.3%5.2%2.3 $2.38 7/15/20202,470,000 shares $6.52 million +11.8%5.6%2.2 $2.64 6/30/20202,210,000 shares $4.95 million +18.2%5.0%2.4 $2.24 6/15/20201,870,000 shares $4.17 million -4.6%4.2%2.9 $2.23 5/29/20201,960,000 shares $5.64 million +3.7%4.5%2 $2.88 5/15/20201,890,000 shares $5.12 million +1.6%4.3%1.5 $2.71 4/30/20201,860,000 shares $5.62 million +10.1%4.2%1.6 $3.02 4/15/20201,690,000 shares $3.84 million +20.7%3.8%1.6 $2.27 3/31/20201,400,000 shares $3.50 million -1.9%3.2%1.6 $2.50 3/13/20201,426,600 shares $3.48 million +18.9%3.3%2.5 $2.44 2/28/20201,200,000 shares $2.77 million +9.1%2.7%2.1 $2.31 2/14/20201,100,000 shares $2.68 million +5.8%2.5%11.1 $2.44 1/31/20201,040,000 shares $2.32 million +19.5%2.4%11.5 $2.23 1/15/2020870,400 shares $1.99 million +3.0%2.0%10.7 $2.29 12/31/2019845,500 shares $2.19 million +0.9%1.9%10.6 $2.59 ENZ Short Interest - Frequently Asked Questions What is Enzo Biochem's current short interest? Short interest is the volume of Enzo Biochem shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 477,500 shares of ENZ short. 1.31% of Enzo Biochem's shares are currently sold short. Learn More on Enzo Biochem's current short interest. What is a good short interest ratio for Enzo Biochem? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ENZ shares currently have a short interest ratio of 6.0. Learn More on Enzo Biochem's short interest ratio. What is a good short interest percentage for Enzo Biochem? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.31% of Enzo Biochem's floating shares are currently sold short. Is Enzo Biochem's short interest increasing or decreasing? Enzo Biochem saw a decrease in short interest during the month of October. As of October 31st, there was short interest totaling 477,500 shares, a decrease of 4.6% from the previous total of 500,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Enzo Biochem's float size? Enzo Biochem currently has issued a total of 52,240,000 shares. Some of Enzo Biochem's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Enzo Biochem currently has a public float of 36,470,000 shares. How does Enzo Biochem's short interest compare to its competitors? 1.31% of Enzo Biochem's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Enzo Biochem: Sera Prognostics, Inc. (4.93%), Biodesix, Inc. (0.29%), EUDA Health Holdings Limited (0.04%), Quipt Home Medical Corp. (2.17%), Exagen Inc. (0.63%), P3 Health Partners Inc. (1.37%), Burning Rock Biotech Limited (0.99%), Concord Medical Services Holdings Limited (0.48%), OpGen, Inc. (0.19%), Psychemedics Co. (0.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Enzo Biochem stock? Short selling ENZ is an investing strategy that aims to generate trading profit from Enzo Biochem as its price is falling. ENZ shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Enzo Biochem? A short squeeze for Enzo Biochem occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENZ, which in turn drives the price of the stock up even further. How often is Enzo Biochem's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENZ, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Sera Prognostics Short Squeeze Biodesix Short Squeeze EUDA Health Short Squeeze Quipt Home Medical Short Squeeze P3 Health Partners Short Squeeze Exagen Short Squeeze Burning Rock Biotech Short Squeeze Concord Medical Services Short Squeeze OpGen Short Squeeze Psychemedics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:ENZ) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enzo Biochem, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enzo Biochem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENZ Stock Alerts